BioSpace News Archive

Innovent Biologics, Inc. announced that the National Medical Products Administration of China has accepted the supplemental New Drug Application for sintilimab in combination with chemotherapy for the first-line treatment of patients with unresectable, locally advanced, recurrent or metastatic gastric or gastroesophageal junction adenocarcinoma.

The Board of Directors of BD has declared a quarterly dividend of $0.87 per common share, an increase of 4.8% from the previous quarter.

Third quarter net sales of $1,069 million increased 19.4%, compared to $895 million in the third quarter of 2020.

Talaris Therapeutics, Inc., a late-clinical stage cell therapy company, provided the first clinical update on its Phase 3 FREEDOM-1 study in living donor kidney transplant recipients, and also separately presented a clinical update and additional data from ongoing follow-up of its fully-enrolled Phase 2 study in LDKT recipients at the 2021 American Society of Nephrology meeting.

DaVita Clinical Research will present eight research abstracts from company representatives and medical professionals during the American Society of Nephrology Kidney Week occurring Nov. 4–7, 2021.

Ironwood Pharmaceuticals, Inc., a GI-focused healthcare company, announced that it is expanding its pipeline by entering into a collaboration and license option agreement with COUR Pharmaceutical Development Company, Inc., a biotechnology company developing novel immune-modifying nanoparticles to treat autoimmune diseases.

NeoGenomics, Inc. announced today an upcoming leadership team transition. William Bonello will be named Chief Financial Officer as of January 1, 2022.

Surface Oncology today reported financial results for the third quarter 2021, and provided a corporate update on recent highlights and anticipated near-term milestones.

NeoGenomics, Inc. today announced its third-quarter results for the period ended September 30, 2021.

Medical Design & Manufacturing today announced all-new programming for the 2021 edition, taking place from December 7 through 9 at the Jacob Javits Convention Center.